GLPGF·B44170106·US·equity·Healthcare - Biotechnology
COMMONSTOCK
GLPGF (GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5) is held by 0 institutional investors as of Q3 2022.
No institutional consensus yet
Fewer than 2 tracked funds currently hold GLPGF (GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5). We surface convergence signals once 2+ institutional funds, insiders, or activists take a position.
This is the correct empty state for thinly-held stocks, not a data issue. New 13F filings arrive quarterly; insider and activist filings update daily.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer